164 related articles for article (PubMed ID: 31279844)
1. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
[TBL] [Abstract][Full Text] [Related]
3. Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Moore LE; Pfeiffer RM; Zhang Z; Lu KH; Fung ET; Bast RC
Cancer; 2012 Jan; 118(1):91-100. PubMed ID: 21717433
[TBL] [Abstract][Full Text] [Related]
4. Altered protein expression in serum from endometrial hyperplasia and carcinoma patients.
Wang YS; Cao R; Jin H; Huang YP; Zhang XY; Cong Q; He YF; Xu CJ
J Hematol Oncol; 2011 Apr; 4():15. PubMed ID: 21489304
[TBL] [Abstract][Full Text] [Related]
5. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
6. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
Zhu CS; Pinsky PF; Cramer DW; Ransohoff DF; Hartge P; Pfeiffer RM; Urban N; Mor G; Bast RC; Moore LE; Lokshin AE; McIntosh MW; Skates SJ; Vitonis A; Zhang Z; Ward DC; Symanowski JT; Lomakin A; Fung ET; Sluss PM; Scholler N; Lu KH; Marrangoni AM; Patriotis C; Srivastava S; Buys SS; Berg CD;
Cancer Prev Res (Phila); 2011 Mar; 4(3):375-83. PubMed ID: 21372037
[TBL] [Abstract][Full Text] [Related]
7. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.
Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A
J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655
[TBL] [Abstract][Full Text] [Related]
8. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
[TBL] [Abstract][Full Text] [Related]
9. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.
Yurkovetsky Z; Ta'asan S; Skates S; Rand A; Lomakin A; Linkov F; Marrangoni A; Velikokhatnaya L; Winans M; Gorelik E; Maxwell GL; Lu K; Lokshin A
Gynecol Oncol; 2007 Oct; 107(1):58-65. PubMed ID: 17659325
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
11. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
12. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of serum metabolites and colorectal cancer risk.
Cross AJ; Moore SC; Boca S; Huang WY; Xiong X; Stolzenberg-Solomon R; Sinha R; Sampson JN
Cancer; 2014 Oct; 120(19):3049-57. PubMed ID: 24894841
[TBL] [Abstract][Full Text] [Related]
14. Validation of serum biomarkers for detection of early- and late-stage endometrial cancer.
Farias-Eisner G; Su F; Robbins T; Kotlerman J; Reddy S; Farias-Eisner R
Am J Obstet Gynecol; 2010 Jan; 202(1):73.e1-5. PubMed ID: 19766980
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
Zaidi AH; Gopalakrishnan V; Kasi PM; Zeng X; Malhotra U; Balasubramanian J; Visweswaran S; Sun M; Flint MS; Davison JM; Hood BL; Conrads TP; Bergman JJ; Bigbee WL; Jobe BA
Cancer; 2014 Dec; 120(24):3902-13. PubMed ID: 25100294
[TBL] [Abstract][Full Text] [Related]
16. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer.
Mu AK; Lim BK; Aminudin N; Hashim OH; Shuib AS
Arch Physiol Biochem; 2016 Jul; 122(3):111-6. PubMed ID: 26849673
[TBL] [Abstract][Full Text] [Related]
17. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry.
Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL
J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment triglycerides-to-high density lipoprotein cholesterol ratio in postmenopausal women with endometrial cancer.
Luo YZ; Yang Z; Qiu YL; Li XH; Qin LQ; Su QS; Mo WN
Kaohsiung J Med Sci; 2019 May; 35(5):303-309. PubMed ID: 30887645
[TBL] [Abstract][Full Text] [Related]
20. Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker.
Ihata Y; Miyagi E; Numazaki R; Muramatsu T; Imaizumi A; Yamamoto H; Yamakado M; Okamoto N; Hirahara F
Int J Clin Oncol; 2014 Apr; 19(2):364-72. PubMed ID: 23700142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
